Génomic Vision SA organizacji Marża zysku
Jaka jest wartość Marża zysku organizacji Génomic Vision SA?
Wartość Marża zysku organizacji Génomic Vision SA to -353.72%
Jaka jest definicja Marża zysku?
Marża zysku (Profit margin) to procent zysku netto z całkowitych dochodów.
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Marża zysku firm w Health Care sektor na EURONEXT w porównaniu do Génomic Vision SA
Czym się zajmuję organizacja Génomic Vision SA?
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
Firmy z marża zysku podobne do Génomic Vision SA
- Wartość Marża zysku organizacji Intu Properties Plc to -355.68%
- Wartość Marża zysku organizacji Victory Offices to -355.14%
- Wartość Marża zysku organizacji Rewalk Robotics Ltd to -355.09%
- Wartość Marża zysku organizacji Charter Hall Long WALE REIT to -354.63%
- Wartość Marża zysku organizacji Ethernity Networks to -354.55%
- Wartość Marża zysku organizacji Diurnal plc to -354.06%
- Wartość Marża zysku organizacji Génomic Vision SA to -353.72%
- Wartość Marża zysku organizacji The Local Shopping REIT PLC to -353.31%
- Wartość Marża zysku organizacji Midland Exploration to -352.38%
- Wartość Marża zysku organizacji Man Sang International to -352.14%
- Wartość Marża zysku organizacji Recce Pharmaceuticals Ltd to -351.09%
- Wartość Marża zysku organizacji Newfield Resources to -350.76%
- Wartość Marża zysku organizacji The Supreme Cannabis Co to -350.75%